Product NDC: | 65649-303 |
Proprietary Name: | XIFAXAN |
Non Proprietary Name: | RIFAXIMIN |
Active Ingredient(s): | 550 mg/1 & nbsp; RIFAXIMIN |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65649-303 |
Labeler Name: | Salix Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021361 |
Marketing Category: | NDA |
Start Marketing Date: | 20100501 |
Package NDC: | 65649-303-03 |
Package Description: | 6 BLISTER PACK in 1 CARTON (65649-303-03) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 65649-303-03 |
Proprietary Name | XIFAXAN |
Package Description | 6 BLISTER PACK in 1 CARTON (65649-303-03) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 65649-303 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | RIFAXIMIN |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20100501 |
Marketing Category Name | NDA |
Labeler Name | Salix Pharmaceuticals, Inc. |
Substance Name | RIFAXIMIN |
Strength Number | 550 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |